Glaucoma Drainage Devices Market to Reach $1.42 Billion by 2030
Updated
Updated · The National Law Review · Aug 10
Glaucoma Drainage Devices Market to Reach $1.42 Billion by 2030
1 articles · Updated · The National Law Review · Aug 10
Summary
$1.42 billion is the projected size of the glaucoma drainage devices market by 2030, up from $0.98 billion in 2026 at a forecast 9.7% CAGR.
$0.89 billion in 2025 grew to $0.98 billion in 2026, driven by rising glaucoma cases, broader use of surgical treatment and an aging population.
700,000 people in the UK are affected by glaucoma, with nearly half undiagnosed, underscoring demand for implants that lower intraocular pressure when drugs or laser therapy fail.
Healthcare expansion is also supporting adoption: UK healthcare spending rose 5.6% in 2023 to about $317.63 billion, improving access to specialized eye care and advanced devices.
North America held the largest market share in 2025, while future growth is expected to come from minimally invasive implants, valved devices and improved biocompatible materials.
With millions silently losing their sight to undiagnosed glaucoma, could breakthrough micro-implants finally halt this global blindness crisis by 2030?
Despite billions pouring into advanced ophthalmic technology, will these revolutionary drainage devices remain out of reach for the average patient?
Will the rapid rise of minimally invasive eye implants make traditional, high-risk glaucoma surgeries completely obsolete in the near future?